In vivo treatment with nanolipid-formulated siRNAs targeting ISG15 leads to enhanced responsiveness to interferon in primary hepatocytes

Authors :: G. Gerken
CI Real
Kerstin Jahn-Hofmann
K Kleinehr
R Bröring
L Ickenstein
Matthias John
Joerg F. Schlaak
Source :: Zeitschrift für Gastroenterologie. 50
Publication Year :: 2012
Publisher :: Georg Thieme Verlag KG, 2012.

Subjects :: Small interfering RNA
Primary (chemistry)
business.industry
In vivo
Interferon
Gastroenterology
Cancer research
Medicine
business
Virology
ISG15
medicine.drug

Tools